Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AASDHPPT Antisense RNA 1 (AASDHPPT-AS1) is a long non-coding RNA that overlaps with the protein-coding gene, AASDHPPT, in an antisense orientation[1]. This lncRNA is classified based on its position relative to AASDHPPT and may participate in regulation of gene expression through antisense or other lncRNA-mediated mechanisms, but its biological functions and relevance to disease are currently undetermined[1]. AASDHPPT-AS1 is not a canonical therapeutic target (such as receptor, enzyme, or transporter), nor are there any known drugs, biomarkers, or safety concerns associated with it. There are no documented aliases beyond its formal name and abbreviation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AASDHPPT Antisense RNA 1 (AASDHPPT-AS1).